EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

HLA Class II Alleles Are Associated With Anti‐Drug Antibodies in Ulcerative Colitis Patients Treated With Etrolizumab

Ashis Saha iD, Mark I McCarthy, Saloumeh K Fischer, Gizette Sperinde, Christian Hammer

HLA · 2026

DOI: 10.1111/tan.70557 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HLA, 2026. Verfasst von Ashis Saha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Genentech, Inc., South San Francisco, California, USA. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Alleles, HLA-DQ beta-Chains, HLA-DQ alpha-Chains. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients treated with etrolizumab, a monoclonal antibody drug for ulcerative colitis, often develop anti‐drug antibodies (ADA) and neutralising antibodies (NAb). To investigate genetic risk factors, we evaluated associations between HLA alleles and ADA/NAb development. HLA‐DQB1*06:03 demonstrated the most significant association with both ADA (OR = 7.3, p ≤ 7.6 × 10 −13 ) and NAb (OR = 13.1, p ≤ 7.7 × 10 −13 ). After controlling for HLA‐DQB1*06:03 , HLA‐DQA1*03:03 emerged as the next most significant allele associated with ADA (OR = 2.8, p ≤ 1.0 × 10 −3 ) and NAb (OR = 5.0, p ≤ 1.3 × 10 −3 ). Notably, all patients carrying both alleles ( n = 5) developed ADA, suggesting these two alleles are sufficient to induce ADA to etrolizumab.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeAllelesHLA-DQ beta-ChainsHLA-DQ alpha-ChainsAntibodies, Monoclonal, HumanizedAntibodies, NeutralizingHumansFemaleMaleAdultMiddle Aged

Stichwörter der Autor:innen

HLAanti‐drug antibodiesetrolizumabneutralising antibodiesulcerative colitis

Substanzen

HLA-DQ beta-ChainsHLA-DQ alpha-ChainsHLA-DQB1 antigenAntibodies, Monoclonal, HumanizedHLA-DQA1 antigenAntibodies, Neutralizing

Autor:innen und Institutionen

  • Genentech, Inc., South San Francisco, California, USA.

ORCID-Profile: Ashis Saha

Zitieren

APA

Saha, A., McCarthy, M. I., Fischer, S. K., Sperinde, G., & Hammer, C. (2026). HLA Class II Alleles Are Associated With Anti‐Drug Antibodies in Ulcerative Colitis Patients Treated With Etrolizumab. HLA. https://doi.org/10.1111/tan.70557

Vancouver

Saha A, McCarthy MI, Fischer SK, Sperinde G, Hammer C. HLA Class II Alleles Are Associated With Anti‐Drug Antibodies in Ulcerative Colitis Patients Treated With Etrolizumab. HLA. 2026. doi:10.1111/tan.70557

BibTeX
@article{Saha2026,
  author = {Saha, Ashis and McCarthy, Mark I and Fischer, Saloumeh K and Sperinde, Gizette and Hammer, Christian},
  title = {HLA Class II Alleles Are Associated With Anti‐Drug Antibodies in Ulcerative Colitis Patients Treated With Etrolizumab},
  journal = {HLA},
  year = {2026},
  doi = {10.1111/tan.70557}
}
Kostenlos starten →